Abstract
The basic properties of differentiated (papillary or follicular) thyroid carcinoma (DTC) are seemingly easy to summarize. Modern surgery and intensive care allow the removal of the primary tumor and possible metastases with very low complication rates. Due to the relatively benign tumor biology and the capacity of differentiated tumor tissue to concentrate radioiodine, prognosis is favorable even if there are lymph node or distant metastases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Benker G, Olbricht T, Reinwein D, Reiners C, Sauerwein W, Krause U, Mlynek ML, Hirche H (1990) Survival rates in patients with differentiated thyroid carcinoma. Influence of postoperative external radiotherapy. Cancer 65: 1517-1520
Brennan MD, Bergstralh EJ, van Heerden JA, McConahey WM (1991) Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 66: 11 - 22
Brierley JD, Tsang RW (1999) External-beam radiation therapy in the treatment of differentiated thyroid cancer. Semin Surg Oncol 16: 42 - 49
Coburn MC, Wanebo HJ (1992) Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg 164: 671 - 676
Cunningham MP, Duda RB, Recant W, Chmiel JS, Sylvester JA, Fremgen A (1990) Survival discriminants for differentiated thyroid cancer. Am J Surg 160: 344 - 347
DeGroot LJ, Kaplan EL, McCormick M, Straus FH (1990) Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71: 414 - 424
Farahati J, Reiners C, Stuschke M, Muller SP, Stuben G, Sauerwein W, Sack H (1996) Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer 77: 172 - 180
Hay ID (1990) Papillary thyroid carcinoma. Endocr Metab Clin North Am 19: 545 - 576
Hermanek P, Henson DE, Hutter RVP, Sobin LH (1993) TNM supplement. A commentary on uniform use. Springer, Berlin Heidelberg New York
Junginger T, Hartel W (1996) Leitlinien der Therapie maligner Schilddrüsentumoren
Leisner B, Degelmann G, Dirr W, Kanitz W, Bull U, Langhammer H, Lissner J, Pabst HW (1982) Behandlungsergebnisse bei Struma maligna 1960-1980. Dtsch Med Wochenschr 107: 1702 - 1707
Lerch H, Schober 0, Kuwert T, Saur HB (1997) Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 15: 2067 - 2075
Mazzaferri EL, Young RL (1981) Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 70: 511 - 518
MSDS (1999) Multizentrische Studie Differenziertes Schilddrüsen Karzinom ( MSDS ). Prospektive randomisierte Phase III-Studie zur perkutanen Strahlentherapie lokal fort geschrittener papillärer and follikulärer Schilddrüsenkarzinome MSDS 99. http://medweb.uni-muenster.de/institute/nukear/msds
Müller-Gärtner HW, Brzac HT, Rehpenning W (1991) Prognostic indices for tumor relapse and tumor mortality in follicular thyroid carcinoma. Cancer 67: 1903 - 1911
O’Connell ME, RP AH, Harmer CL (1994) Results of external beam radiotherapy in differentiated thyroid carcinoma: a retrospective study from the Royal Marsden Hospital. Eur J Cancer 30 A: 733 - 739
Philips P, Hanzen C, Andry G, Van Houtte P, Fruuling J (1993) Postoperative irradiation for thyroid cancer. Eur J Surg Oncol 19: 399 - 404
Puskâs C, Schober O (1999) Adjuvante perkutane Radiatio lokal fortgeschrittener papillärer and follikulärer Schilddrüsenkarzinome: Überlegungen vor dem Start einer prospektiven Multicenterstudie. Nuldearmed 38: 232 - 323
Reinhardt M, Guttenberger R, Slanina J, Frommhold H, Moser E (1995) Indikationen zur perkutanen Strahlentherapie beim Karzinom der Schilddruse. Freiburger Konsensus. Radiologe 35: 535-539
Samaan NA, Maheshwari YK, Nader S, Hill CS, Jr., Schultz PN, Haynie TP, Hickey RC, Clark RL, Goepfert H, Ibanez ML, Litton CE (1983) Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab 56: 1131 - 1138
Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, Ordonez NG (1992) The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab 75: 714 - 720
Sautter-Bihl ML (1997) Hat die perkutane Strahlentherapie einen Stellenwert in der Behandlung des Schilddrüsenkarzinoms? Onkologe 3: 48 - 54
Sautter-Bihl ML, Herbold G, Heinze HG, Bihl H (1991) Postoperative external radiotherapy of differentiated thyroid carcinoma: when is radioiodine therapy alone inadequate? The dosimetric considerations with a Monte Carlo simulation. Strahlenther Onkol 167: 267 - 272
Sautter-Bihl ML, Schmitt G, Willich N, Seegenschmiedt MH (1998) Pertkutane Radiotherapie der Struma maligna. AWMF-Leitlinienregister Nr. 052 /001. http://gopher.rz.uni-duesseldorf.de/www/awmf
Scheumann GF, Gimm 0, Wegener G, Hundeshagen H, Dralle H (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18:559-567; discussion 567 - 568
Shaha AR, Shah JP, Loree TR (1996) Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann Surg Oncol 3: 534 - 538
Sherman SI (1999) Toward a standard clinicopathologic staging approach for differentiated thyroid carcinoma. Semin Surg Oncol 16: 12 - 15
Sherman SI, Brierley JD, Sperling M, Ain KB, Bigos ST, Cooper DS, Haugen BR, Ho M, Klein I, Ladenson PW, Robbins J, Ross DS, Specker B, Taylor T, Maxon HR (1998) 3rd Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 83: 1012-1021
Simpson WJ, Carruthers JS (1978) The role of external radiation in the management of papillary and follicular thyroid cancer. Am J Surg 136: 457 - 460
Simpson WJ, Panzarella T, Carruthers JS, Gospodarowicz MK, Sutcliffe SB (1988) Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys 14: 1063 - 1075
Smedal MI, Salzman FA, Meissner WA (1967) The value of 3 my roentgen-ray therapy in differentiated thyroid carcinoma. Am J Roentgenol Radium Ther Nucl Med 99: 352 - 364
Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB (1998) The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 82: 375 - 388
Tubiana M, Haddad E, Schlumberger M, Hill C, Rougier P, Sarrazin D (1985) External radiotherapy in thyroid cancers. Cancer 55: 2062 - 2071
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Puskás, C., Biermann, M., Willich, N., Schober, O. (2001). Percutaneous Radiation Therapy. In: Biersack, HJ., Grünwald, F. (eds) Thyroid Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-04610-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-662-04610-4_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-04612-8
Online ISBN: 978-3-662-04610-4
eBook Packages: Springer Book Archive